M. Fonfría

Trastuzumab for the treatment of salivary duct carcinoma.

R. Tishler, D. Dillon, R. Haddad, 2013, The oncologist.

Machine Learning Models and Multiparametric Magnetic Resonance Imaging for the Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer

E. Martínez de Dueñas, M. Fonfría, S. Olmos Antón, 2022, Cancers.

Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families

I. Chirivella, A. Segura, I. Tena, 2021, Journal of personalized medicine.

Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature

K. Pacak, A. Cañete, J. Balaguer, 2018, Clinical Medicine Insights. Oncology.

Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice.

J. Aparicio, A. Segura, J. Montalar, 2014, JOP : Journal of the pancreas.

Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy

R. Díaz, M. Juan, A. Tormo, 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization

I. Chirivella, T. Ramón Y Cajal, P. Berbel, 2020, Cancers.